Laurus Labs Limited

Laurus Labs Ltd is an innovation-driven pharmaceutical and biotechnology company headquartered in Hyderabad, India. Established in 2005, the company specializes in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and contract research and manufacturing services (CRAMS) for the global generics sector. Laurus Labs operates state-of-the-art manufacturing facilities accredited by global regulatory agencies including the US FDA, WHO, and EUGMP, serving clients across more than 50 countries.

The company’s core therapeutic segments include antiretroviral (ARV), oncology, cardiovascular, anti-diabetic, and anti-asthmatic medications. With a robust pipeline of R&D projects, Laurus Labs has expanded into biotechnology and synthesis of novel compounds, leveraging vertical integration to ensure quality, cost competitiveness, and sustainable growth.